Issue 219

15.10.2021

Europe
USA
Latam & Caribbean
APAC
Africa & Middle East

HIGHLIGHTS 

 

PROHIBITION HOLDINGS COMMENCES SERIES B FUNDING ROUND TO DEVELOP B2B MARKETPLACE

Stephen Murphy, Prohibition Holdings Co-founder & CEO, spoke with Business Insider about the Series B funding round and about filling a critical need for transparency and convenience in the cannabis supply chain – particularly in Europe.

The cannabis industry, Murphy says, can be ‘somewhat unsettling for investors & operators, but our new marketplace platform brings convenience to B2B trade’. With highly respected brands already in Prohibition’s portfolio, the Series B pitch deck provides an overview of future vision of the group, and is available exclusively at Business Insider.

READ MORE »

 


 

NEVADA OFFICIALS REPORT US$1 BILLION IN ADULT-USE CANNABIS SALES OVER THE PAST YEAR

READ MORE »

 

MALTESE EQUALITY MINISTER RELEASES DRAFT CANNABIS BILL TO LEGALISE ADULT-USE CANNABIS

READ MORE »

Europe

  • The number of hemp fields in Germany rise by 17% after an increase in farming operations in 2021.
  • The Irish health ministry to challenge the European Court of Justice ruling that considers CBD as a food.
  • High Tide enters the UK CBD market after its successful acquisition of Scottish online CBD retailer Blessed for £11 million.
  • US firm Casa Verde enters Europe with €15 million investment in Portuguese cannabis company Acecann.
  • UK’s Hemp-30 project receives £200,000 in government backing in order to boost hemp production 100-fold.
  • German pharmaceutical association increases its services range to include cannabis for palliative care patients.
  • The UK Food Standards Agency delays publication of the final list of CBD vendors, still with no date set.
  • Canadian company to acquire 80% of Leli Holland, which is licensed to supply coffeeshops during Dutch experiment.
  • Leaders of German police unions support cannabis prohibition, calling on politicians to put a stop to cannabis legalisation.

USA

EXCLUSIVE

DUTCH MEDICAL CANNABIS SALES CONTINUE DOWNWARD TREND IN 2021

The number of medical cannabis sales in the Netherlands declined in H1 of 2021, continuing a downward trend, which began in 2018 when insurance reimbursements were halted in the country.

The number of medical cannabis patients has also been declining since this time. However, increasing overall value of sales and quantities sold to pharmacies from 2019 to 2020 suggest that individual patients may be consuming more medical cannabis each year.

READ MORE »

CANADA

LATAM & CARIBBEAN

Exclusive

 

ONEGLOBAL ANNOUNCED AS BRONZE SPONSOR OF CANNABIS EUROPA LONDON

UK-based insurance and reinsurance broker company Oneglobal has been announced as the Bronze Sponsor of the upcoming Cannabis Europa London conference on 10–11 November. Oneglobal reinvigorates the brokering world with its ambitious plans for the future, improving the way in which businesses around the world manage risk via insurance.

Investors, policy makers and influential cannabis-industry leaders will come together to help shape the future of cannabis in Europe at Cannabis Europa London.

READ MORE »

 

APAC

  • Nepalese Minister for Health supports a bill to legalise cultivation of up to six plants without a licence.
  • Clinical drug company Emyria to join Palantir Technology’s foundry builders programme with access to data platforms.
  • ECS Botanics reports a revenue increase of 123% for Q3 2021 with AU$900,000 in sales.
  • Heritage Cannabis completes C$60,000 export of its CBD and CBDA filmstrips to two Australian companies.
  • Ministers for parliament in Western Australia to examine medical cannabis laws, to allow easier access for patients.
  • Medical cannabis company Greenfern Industries announces NZX listing for the end of October.

AFRICA & MIDDLE EAST

Read the stories that shape the cannabis industry